The decision to fund medications to treat H.I.V.-AIDS patients in sub-Saharan Africa and the Caribbean flew in the face of expert advice. But the U.S. did it anyway.
An estimated 20 percent of Russia prisoner recruits are H.I.V. positive. To some, the front lines seemed less risky than prisons where they said they were denied effective treatments.